If you’re in the life sciences industry, you know that raising capital is essential, but it’s also a challenge that can be as complex as your R&D. The opportunities your innovative work presents can be very attractive to investors, but the risk is also high. In our experience, understanding the current funding landscape and implementing strategic financial practices are critical for successfully navigating your funding rounds.
The Current Funding Landscape
Biotech and life sciences continue to attract investors thanks to the promise of groundbreaking therapies and technologies. Large pharmaceutical companies are also keen to acquire emerging innovations, meaning that mergers and acquisitions (M&A) are also active.
However, companies also have to contend with high interest rates, geopolitical uncertainties, and lengthy R&D timelines, while investors need to understand specialized science. Despite these challenges, developing a straightforward narrative about your company’s innovation and impact can help secure funding.
What are Investors Looking For?
Investors focus on several critical aspects when they’re evaluating investment opportunities. These are the areas that you should focus on in any funding pitches:
- Revenue Potential: Does the product have strong commercial viability, including robust IP and a sizeable market opportunity? Is there a clear path to profitability? Partnering with the right financial experts can help you ensure accurate forecasting, cost control and revenue optimization to share with investors.
- Financial Strategy: Expert financial services providers can help you develop a clear and well-defined funding plan, evidence of disciplined financial management, and a roadmap to sustained growth that will assure investors about long-term returns.
- Capital Efficiency: How effectively does the company allocate resources to maximize value creation and minimize unnecessary financial risk? You need to demonstrate optimized capital allocation, streamlined operations, and a clear strategy for dealing with any cash flow challenges.
- Regulatory Pathway: How realistic and efficient is the product’s approval process? How do regulatory hurdles and market dynamics impact the financial outlook and potential return on investment? A strong financial team can help your company manage compliance costs, market-entry expenses, and risk factors.
- Management Team: Are the founders and executives equipped with the expertise and leadership skills to scale operations, manage burn rates, and deliver investor value? Do they have access to expert financial advice that rounds out and improves their decision-making capabilities?
- ESG Performance: Research shows investors are becoming more interested in your company’s alignment with ESG principles. Firms with a strong ESG approach are seen as less risky and better positioned for long-term growth, as many investors recognize that companies that consider their social and environmental impact tend to be more resilient. A knowledgeable financial partner can provide critical understanding of how to make ESG efforts financially sustainable and deliver compliance reporting, ESG reporting services, and risk mitigation strategies.
Key Tax and Accounting Considerations for Fundraising
As well as understanding how to build confidence in your investors, there are some critical tax and accounting considerations that you need to pay attention to:
- Equity Structuring: Structure equity in your firm to balance ownership and attract investors.
- R&D Tax Credits: Take advantage of appropriate credits and incentives for qualifying research expenditures.
- Revenue Recognition: This is especially important for the consistency and integrity of financial reports when you use them in decision making.
- Valuation: Ensure your company is accurately valued to avoid future tax complications.
- Audit Readiness: Maintain clean financial records for due diligence by potential investors.
- Drawdowns: Most grants will specify how you are to use the grant funds and keep track of expenses. Failing to comply with the grant conditions can result in the company losing those funds.
Strategies for Success
Our experience with clients is that raising capital or wooing investors is easier when your business pays attention to all the details:
- Build a strong financial model: A robust financial model that clearly outlines revenue projections, cost structures, and growth potential will help investors see future financial performance and the potential for a return on their investment.
- Document your financials properly: You will be presenting the financials of your business to experienced investors. They will expect professionally documented details and a robust accounting system. Have a solid financial model that shows a pathway to a solid return on investment.
- Decide on the appropriate source of funding: You need to approach different kinds of investors depending on whether you, for example, want to sell a portion of your equity or not. Choosing the right funding source impacts ownership, financial stability, and long-term growth.
- Plan for what happens after you raise capital: Raising capital is just a step on your journey. You should develop a detailed budget with strategic milestones for when you secure the funding. Continue to monitor your cash flow and create a contingency fund for unexpected delays or expenses.
- Build a strong narrative. Clearly articulate your company’s science, goal, and mission and what you want to achieve. This also includes the timeline of your research and development.
- Be persistent. Raising capital can take time and involve many rejections. Stay focused and adapt as needed.
Successfully raising capital relies on the right combination of scientific excellence, strategic financial management, and clear communication with your potential investors. Whether you’re preparing for your first funding round or managing existing capital, working with experienced financial partners can significantly strengthen your fundraising efforts.
